Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

摘要

The present invention relates to new compounds of formula 1,
to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.